MedMira | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,021 results for “MedMira”

Trials

View all 903 →

A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.

1,300 participants · First posted Sep 19, 2024

Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea

280 participants · First posted Jan 9, 2012

Medications in Breast Milk: A Convenience Pharmacokinetic Study

30 participants · First posted Oct 29, 2021

Drugs

View all 30 →

MEDICA-40

SMOC2(Mediar)

Estrogen(MEDIR)

Organizations

View all 22 →

MedMira Laboratories Inc

Canada

Dermira, Inc.

United States

Medcura, Inc.

United States

News

View all 66 →

MedMira's Reveal G4 Rapid HIV-1/2 Test Approved by Health Canada for Point-of-Care Use

MedMira's Reveal® G4 HIV-1/2 Rapid Test Achieves 100% Specificity in Clinical Trials; Awaits CLIA Waiver

MedMira Secures Health Canada Approval for HIV/Syphilis Test Amid Regulatory Progress

Page 1 of 103